I am a recognized leader in peptide discovery and have recently joined the University of Indiana as a Senior Research Scientist. Prior to this role, I served as a Senior Research Advisor and Group Leader of Peptide Chemistry at Eli Lilly and Co., and as Peptide Chemistry Group Leader with Amgen, Inc. My expertise spans over 30 years in natural peptide synthesis and GPCR drug discovery, with a focus on endocrine and diabetes therapeutics.
I hold a B.S. in biochemistry from Northwestern University and a M.S. and Ph.D. in medicinal chemistry from Purdue University. Throughout my career, I have contributed to the advancement of six molecules into clinical trials and have authored or co-authored more than 50 publications and 15 applied or issued patents. I currently sit on numerous advisory and editorial boards, furthering my contributions to the field of peptide chemistry.
Key Milestone Expertise in Drug Discovery & Development:
- Lead Identification
- Lead Optimization
- Predevelopment (candidate selection)
- IND enabling
